Daily Visitors
Last scanned
Domain Age
Global Rank
Updated:
VENCLEXTA® (venetoclax tablets) AML & CLL/SLL Treatment HCP Site
Select a VENCLEXTA® indication. VENCLEXTA is an oral therapy for select AML, CLL and SLL patients. See full safety and Prescribing Information for more details.
This website is hosted with Amazon.com, Inc., which reserves the following IP addresses for venclextahcp.com: 13.57.115.189, 52.53.58.102. Moreover, DNS used with this website include ns11.constellix.com, ns21.constellix.com, ns31.constellix.com, ns41.constellix.net, ns51.constellix.net, ns61.constellix.net. Subnet identifier ranges from 54.151.0.0 to 54.151.127.255. Classless Inter-Domain Routing (CIDR) is 54.151.0.0/17. ARIN net type is Reallocated.
Daily Visitors
Last scanned
Domain Age
Global Rank
ns11.constellix.com
ns21.constellix.com
ns31.constellix.com
ns41.constellix.net
ns51.constellix.net
ns61.constellix.net
{{value}}
2016-07-11
2024-07-11
MarkMonitor Inc.
{{value}}
The registrar of venclextahcp.com is MarkMonitor Inc. and the name expires on 2024-07-11. According to open source data, you can reach the owner at internetnameregistrar@abbvie.com but please make sure you have a good reason for unsolicited messages. Their country of residence is United States of America.
N/A
534
N/A
N/A
N/A
N/A
N/A
N/A
284.7K
N/A
N/A
534